See this week’s Item #2.
Read More »Yearly Archives: 2011
Novo Nordisk Announces U.S. Launch of NovoTwist®
Novo Nordisk has announced the launch of the NovoTwist® pen needle in the United States. It is available for use with Novo Nordisk pre-filled delivery devices, including Levemir® FlexPen®, NovoLog®, FlexPen®, Victoza® Pen and other Novo Nordisk pens, and is the first single-twist needle cleared for use in the United …
Read More »Multiple Pregnancies May Increase Risk of Obesity, Diabetes
Multiple pregnancies may increase the risk of obesity, diabetes and the buildup of plaque in the arteries, suggests new research in mice. Scientists from the University of Cincinnati and colleagues studied mice late in gestation in either their first or fourth pregnancy. Those in their fourth pregnancy had severe glucose …
Read More »Cost of Care for Youth with Diabetes is Six Times Higher than for Youth without the Disease
Researchers from the CDC examined health insurance claims made in 2007 for nearly 50,000 youth aged 19 and younger, including 8,226 with diabetes. Annual medical expenses for youth with diabetes were $9,061, compared with $1,468 for those without diabetes. Prescription drugs and outpatient care accounted for much of the extra …
Read More »Diabetes Up in U.S. Cats and Dogs
Diabetes diagnoses are rising at an even faster rate among dogs and cats than their human companions, according to a national analysis of pet health released this week. Diabetes rates increased by nearly a third among dogs in the last four years and by 16% among cats. It is much …
Read More »FDA Approves New DPP-IV Inhibitor: Tradjenta (Linagliptin)
A new prescription medication Tradjenta (linagliptin) has gained FDA approval for the treatment of adult Type 2 diabetes. Tradjenta will compete with two other drugs in the same family, Onglyza and Januvia.…
Read More »New Mechanism Identified That May Provide Potential Cure for Diabetes
Researchers from UCLA’s Larry L. Hillblom Islet Research Center have discovered the underlying mechanism that could convert other cells in the body into insulin-making cells, which could provide a potential cure for diabetes.…
Read More »Self-Monitoring Eases Doctors’ Reluctance to Start Insulin
Glucose monitors and at-home record-keeping improved outcomes for orally managed diabetics with poorly controlled disease — by prompting their doctors to put them on insulin faster….
Read More »Why Gastric Bypass Surgery Cures Type 2 Diabetes
Gastric bypass surgery is great for curing Type 2 diabetes. It works for almost 80% of patients. Now scientists are beginning to figure out why and weight loss may be the least of it.…
Read More »Can Liraglutide Antibodies Affect Its Efficacy?
Researchers looked at antibody formation when liraglutide (Victoza) is used and whether that has an impact on glycemic efficacy or safety.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.